A Rare Cause of Extreme Leukocytosis: Primary Plasma Cell Leukemia with High-risk Cytogenetics

Author:

Sonmez Ozge1,Elverdi Tugrul1,Tekin Tuba Ozkan2,Kaya Selin Kucukyurt3,Akı Suat Hilal1,Salihoglu Ayse3

Affiliation:

1. Cerrahpasa Medical School: Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi

2. Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi

3. İstanbul Üniversitesi-Cerrahpaşa Cerrahpaşa Tıp Fakültesi: Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi

Abstract

Abstract Background Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell disorder. Extreme leukocytosis is an infrequent finding in pPCL. Case presentation: We reported an 82-year-old female patient who presented with marked leukocytosis (61.900/µl) and was diagnosed with pPCL. Plasma cells were found to have t(14;20) and 1q21 amplification. Following partial response after two cycles of bortezomib/dexamethasone combination, central nervous system (CNS) relapse occurred. Due to the advanced age and frailty, no further therapy could be administered. She had a fulminant disease course and died within one month of the CNS involvement. Conclusion PCL should be included in the differential diagnosis of leukocytosis.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3